Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis (Q42987036)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 April 2009

Language	Label	Description	Also known as
English	Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis	scientific article published on 21 April 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Georges-Philippe Pageaux

4

object named as

Georges-Philippe Pageaux

0 references

author name string

Hélène Peyrière

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ludmilla Tatem

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Camille Bories

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Georges-Philippe Pageaux

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jean-Pierre Blayac

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Dominique Larrey

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

21 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

973-977

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Buprenorphine: a review of its pharmacological properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Hepatitis after intravenous buprenorphine misuse in heroin addicts

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Acute hepatitis due to buprenorphine administration

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

A method for estimating the probability of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Clinical pharmacology of buprenorphine: ceiling effects at high doses

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Mitochondrial dysfunction in hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Resolution of chronic hepatitis C following parasitosis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Spontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Cellular immune responses against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Spontaneous clearance of hepatitis C virus after long-term opiate dependence therapy with buprenorphine

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Morphine Enhances Hepatitis C Virus (HCV) Replicon Expression

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Spontaneous negativation of serum hepatitis C virus RNA is a rare event in type C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L628

21 January 2018

Identifiers

10.1345/APH.1L628

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

release_hjkvbi3dordzfoqig76r2xnl6i

1 reference

https://api.fatcat.wiki/v0/release/hjkvbi3dordzfoqig76r2xnl6i

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42987036&oldid=1975882383"